1. Reactive Oxygen Species in the Cerebral Circulation

   • Tamara M. Paravicini
   • Grant R. Drummond
   • Christopher G. Sobey

   Leading Article 17 September 2012 Pages: 2143 - 2157

   

2. Management of Invasive Candidiasis in Critically Ill Patients

   • Stijn Blot
   • Koenraad Vandewoude

   Therapy In Practice 17 September 2012 Pages: 2159 - 2175

   

3. Role of Fibric Acid Derivatives in the Management of Risk Factors for Coronary Heart Disease

   • Jean-Pierre Després
   • Isabelle Lemieux
   • Sander J. Robins

   Review Article 17 September 2012 Pages: 2177 - 2198

   

4. Antiepileptic Drugs in the Treatment of Anxiety Disorders

   • Michael Van Ameringen
   • Catherine Mancini
   • Mark Bennett

   Review Article 17 September 2012 Pages: 2199 - 2220

   

5. Prulifloxacin

   • Susan J. Keam
   • Caroline M. Perry

   Adis Drug Profile 17 September 2012 Pages: 2221 - 2234

   

6. Prulifloxacin

   • Pietro E. Varaldo

   Guest Commentary 17 September 2012 Pages: 2235 - 2235

7. Prulifloxacin

   • Claudio Giberti

   Guest Commentary 17 September 2012 Pages: 2235 - 2236

8. Lumiracoxib

   • Katherine A. Lyseng-Williamson
   • Monique P. Curran

   Adis Drug Profile 17 September 2012 Pages: 2237 - 2246

   

9. Lumiracoxib

   • Paola Patrignani

   Guest Commentary 17 September 2012 Pages: 2247 - 2247

10. Lumiracoxib

    • Hyman Tannenbaum

    Adis Drug Profile 17 September 2012 Pages: 2247 - 2248

11. Anidulafungin

    • David Murdoch
    • Greg L. Plosker

    Adis Drug Profile 17 September 2012 Pages: 2249 - 2258

    

12. Anidulafungin

    • William J. Steinbach

    Adis Drug Profile 17 September 2012 Pages: 2259 - 2259

13. Anidulafungin

    • José A. Vazquez

    Adis Drug Profile 17 September 2012 Pages: 2259 - 2260